Chargement en cours...
Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
Results from two randomised global trials (SOFT & TEXT) designed to newly define the most effective components of adjuvant endocrine therapy for premenopausal women with endocrine responsive disease, showed that for some, those with high risk of relapse, the use of the aromatase inhibitor exemes...
Enregistré dans:
| Publié dans: | Ecancermedicalscience |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Cancer Intelligence
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4462884/ https://ncbi.nlm.nih.gov/pubmed/26082801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.544 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|